Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 18/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 8/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 7/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6482019 | 0.90 | PDE4A (0.47) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6772740 | 0.90 | PDE4A (0.42) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6706658 | 0.81 | PDE4A (0.45) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6825700 | 0.80 | PDE4A (0.45) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6772615 | 0.77 | TLR7 (0.43) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6481387 | 0.76 | PDE4B (0.43) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6769137 | 0.72 | PDE4A (0.46) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6773704 | 0.70 | PDE4A (0.41) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6772893 | 0.69 | PDE4A (0.42) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6768490 | 0.69 | PDE4A (0.38) | PDE4APDE4DPDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1043324-B1 | PURINE DERIVATIVES AND MEDICINE CONTAINING THE SAME AS THE ACTIVE INGREDIENT | MITSUBISHI CHEM CORP (JP) | 2004-06-16 | — | — | EP | claimed |
| US-6734187-B1 | ANTIASTHMATIC AGENTS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-05-11 | — | — | US | claimed |
| US-6660745-B1 | Phosphodiesterase inhibitors; treatment of asthma, chronic obstructive pulmonary disease, inflammatory disorders | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-12-09 | — | — | US | claimed |
| EP-1178046-B1 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEM CORP (JP) | 2003-11-19 | — | — | EP | claimed |
| EP-1178046-A1 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-06 | — | — | EP | claimed |
| EP-1043324-A1 | PURINE DERIVATIVES AND MEDICINE CONTAINING THE SAME AS THE ACTIVE INGREDIENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-10-11 | — | — | EP | claimed |
| US-6936633-B2 | Pyrrolidinone derivatives | UCB S.A. (BE) | 2005-08-30 | — | — | US | disclosed |
| US-6919455-B2 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-07-19 | — | — | US | disclosed |
| CN-1160355-C | Purine derivative dihydrate, drug containing the compound as active ingredient, and intermediate for production thereof | ������ѧ��ʽ���� | 2004-08-04 | — | — | CN | disclosed |
| EP-1043324-B1 | PURINE DERIVATIVES AND MEDICINE CONTAINING THE SAME AS THE ACTIVE INGREDIENT | MITSUBISHI CHEM CORP (JP) | 2004-06-16 | — | — | EP | disclosed |
| US-6734187-B1 | ANTIASTHMATIC AGENTS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-05-11 | — | — | US | disclosed |
| US-20040077665-A1 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-04-22 | — | — | US | disclosed |
| US-20040077665-A1 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-04-22 | — | — | US | disclosed |
| EP-1178046-B1 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEM CORP (JP) | 2003-11-19 | — | — | EP | disclosed |
| EP-1178046-A4 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEM CORP (JP) | 2002-06-05 | — | — | EP | disclosed |
| CN-1350535-A | Purine derivative dihydrate, drug containing the compound as active ingredient, and intermediate for production thereof | MITSUBISHI CHEM CORP (JP) | 2002-05-22 | — | — | CN | disclosed |
| EP-1178046-A1 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-06 | — | — | EP | disclosed |
| EP-1178046-A1 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-06 | — | — | EP | disclosed |
| WO-2000068231-A1 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-11-16 | — | — | WO | disclosed |
| EP-1043324-A1 | PURINE DERIVATIVES AND MEDICINE CONTAINING THE SAME AS THE ACTIVE INGREDIENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077665-A1 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | DPYD, NUDT1, PNP | PDE4A 4/4885PDE4D 21/4885PDE4B 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.